Literature DB >> 17504655

Changing paradigms in the immunological science of allergy.

Edward J Goetzl1.   

Abstract

The nonallergic roles of mast cells in infections and immune tolerance recently have been elucidated more fully at mechanistic levels. Mast cells that have been activated by contact with microbial surfaces secrete chemotactic mediators capable of attracting leukocytes through blood vessels permeabilized by other mediators. In the setting of allograft transplantation, regulatory CD4 T cells promote tolerance both by direct immunosuppressive effects and by releasing interleukin (IL)-9 that attracts and stimulates differentiation of mast cells with the capacity to induce local tolerance. For the first time in over 20 years, two new subclasses of CD4 T cells have been identified that have major immune functions. The first are T-helper interleukin-17 (T(H)17) cells, which mediate acute and chronic inflammation in recurring exacerbations of autoimmune diseases, and the second are sets of adaptive regulatory T cells, which control CD4 effector T cells and other immune effector cells by secreting transforming growth factor-beta or IL-10.

Entities:  

Mesh:

Year:  2007        PMID: 17504655     DOI: 10.1007/s11882-007-0024-0

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  10 in total

Review 1.  The role of CD4+ T-cell subsets in determining transplantation rejection or tolerance.

Authors:  D Zelenika; E Adams; S Humm; C Y Lin; H Waldmann; S P Cobbold
Journal:  Immunol Rev       Date:  2001-08       Impact factor: 12.988

Review 2.  Mast-cell responses to pathogens.

Authors:  Jean S Marshall
Journal:  Nat Rev Immunol       Date:  2004-10       Impact factor: 53.106

Review 3.  Mast cells as "tunable" effector and immunoregulatory cells: recent advances.

Authors:  Stephen J Galli; Janet Kalesnikoff; Michele A Grimbaldeston; Adrian M Piliponsky; Cara M M Williams; Mindy Tsai
Journal:  Annu Rev Immunol       Date:  2005       Impact factor: 28.527

4.  Analysis of the underlying cellular mechanisms of anti-CD154-induced graft tolerance: the interplay of clonal anergy and immune regulation.

Authors:  Sergio A Quezada; Kathy Bennett; Bruce R Blazar; Alexander Y Rudensky; Shimon Sakaguchi; Randolph J Noelle
Journal:  J Immunol       Date:  2005-07-15       Impact factor: 5.422

Review 5.  New IL-12-family members: IL-23 and IL-27, cytokines with divergent functions.

Authors:  Christopher A Hunter
Journal:  Nat Rev Immunol       Date:  2005-07       Impact factor: 53.106

Review 6.  Th17: an effector CD4 T cell lineage with regulatory T cell ties.

Authors:  Casey T Weaver; Laurie E Harrington; Paul R Mangan; Maya Gavrieli; Kenneth M Murphy
Journal:  Immunity       Date:  2006-06       Impact factor: 31.745

7.  Mast cells are essential intermediaries in regulatory T-cell tolerance.

Authors:  Li-Fan Lu; Evan F Lind; David C Gondek; Kathy A Bennett; Michael W Gleeson; Karina Pino-Lagos; Zachary A Scott; Anthony J Coyle; Jennifer L Reed; Jacques Van Snick; Terry B Strom; Xin Xiao Zheng; Randolph J Noelle
Journal:  Nature       Date:  2006-08-20       Impact factor: 49.962

8.  Interleukin 27 limits autoimmune encephalomyelitis by suppressing the development of interleukin 17-producing T cells.

Authors:  Marcel Batten; Ji Li; Sothy Yi; Noelyn M Kljavin; Dimitry M Danilenko; Sophie Lucas; James Lee; Frederic J de Sauvage; Nico Ghilardi
Journal:  Nat Immunol       Date:  2006-08-13       Impact factor: 25.606

Review 9.  Interleukin-17 family members and inflammation.

Authors:  Jay K Kolls; Anders Lindén
Journal:  Immunity       Date:  2004-10       Impact factor: 31.745

10.  Induction of FoxP3 and acquisition of T regulatory activity by stimulated human CD4+CD25- T cells.

Authors:  Mindi R Walker; Deborah J Kasprowicz; Vivian H Gersuk; Angele Benard; Megan Van Landeghen; Jane H Buckner; Steven F Ziegler
Journal:  J Clin Invest       Date:  2003-11       Impact factor: 14.808

  10 in total
  1 in total

Review 1.  IL-9: basic biology, signaling pathways in CD4+ T cells and implications for autoimmunity.

Authors:  Hongmei Li; Abdolmohamad Rostami
Journal:  J Neuroimmune Pharmacol       Date:  2009-12-18       Impact factor: 4.147

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.